Trends in Commercial Support of CME
This article is an edited transcript of the June 2006, Pharma Marketing Roundtable discussion, which was devoted to trends in commercial support of CME.
Pharma Marketing News Vol. 5, #1
Vol. 5, No. 1: January 2006 Welcome to the January, 2006 issue of Pharma Marketing News. Subscribe Now to get...
How to Piss Off KOLs
Key Opinion Leaders -- or KOLs as they are known by pharmaceutical marketers -- are physicians who influence their peers' medical practice, including but...
FDA Gets a “C” from the Public
Seems like a lot of Harris/Wall Street Journal polls are crossing my path lately (see, for example, "Doing a Good Job but Still No...
Doing a Good Job but Still No Respect!
The late, great comedian Rodney Dangerfield made the phrase "I get no respect" his trademark. Some pharmaceutical executives these days have embraced the Rodney...
More Reminder Ad Sightings
Reports of the demise of pharmaceutical "reminder ads" (eg, "Reminder Ads - Pharma's Dodo?") have been greatly exaggerated.Since PhRMA's Guiding Principles for Direct to...
3rd Annual Forum on Field-Based Dissemination of Scientific Information
Effective and Compliant Medical Communication Strategies for Appropriate Information Exchange
Product Relaunch Summit
Successfully relaunching a pharmaceutical product is a difficult process.
Proper Pharma Use of Rx Data
Yesterday I posted a critique of an article in the May 2006 issue of the venerable Pharmaceutical Executive Magazine, affectionately known as PE to...
Specious Arguments in Favor of Rx Data Use
IMS Health -- the company that sells physician prescribing data to pharmaceutical companies -- is working overtime these days to stem the rising tide...
